COPD

Depression & anxiety in COPD patients respond well to pulmonary rehabilitation but how to proceed safely in patients with comorbid CVD?

New GOLD guidelines, strategies, and challenges highlighted the key developments for primary care physicians in 2019.

Test your knowledge of the latest developments in a complicated and rapidly changing area of patient care.

How much do you know about the various comorbidities COPD patients face? Test your knowledge with our quick, 5-question quiz. 

Combination therapy found to reduce COPD exacerbations, no exacerbation reduction with β-blockers, plus 3 more must-read studies. 

How are COPD patients using synthetic cannabinoids? Do breathing exercises always improve symptoms? Answers and more questions in this quick quiz.

Findings: COPD patients who are lonely and depressed are at increased risk for ED use and hospital admission. Even mild depression is a risk factor.

Findings: Don’t blame patients for all inhaler-use errors; singing may help improve breathing, QOL; Rx adherence does improve over time; plus 3 more outcomes of interest.

Can air pollution cause emphysema? Can yoga positively impact lung function? New research has answers to these questions plus 5 more.

E-cigarette vapor may worsen COPD. A new study demonstrates exposure-related death of human airway smooth muscle cells and other toxic effects.

Primary care patients with COPD may be at increased risk for T2DM, according to new research. Screening could increase early diagnosis.

Not all that glitters is GOLD, prevalence of asthma-COPD overlap in primary care, and 4 more new studies in COPD, asthma, and overlap highlighted. 

Are you up-to-date on the latest COPD research? Brush-up with this quick, 5-question quiz. 

Second-hand smoke and COPD, optimal cutoff for COPD diagnosis, impact of exercise on COPD risk, and 3 more new findings, at-a-glance.

Confirmed: FEV1:FVC <0.70 proves to be the optimal threshold to identify risk of COPD vs less than LLN and other fixed values.

The 2019 GOLD Guidelines make a new distinction in how to choose initial and subsequent COPD treatment. Do you know what that is? Answer and 4 more questions, here.

Consequences of a late COPD diagnosis, a blood test to stratify mortality risk, and 6 other new studies offer insights into improving care for COPD patients.

DALLAS--Results of 3 studies presented at the American Thoracic Society meeting this week focus on the predictive role of disease exacerbations, machine learning, and Hgb levels in COPD. 

Highlights: The first liquid solution of colchicine for prophylaxis of gout, the first generic version of Advair Diskus, and 8 more new and approved drugs.

More than one-third of those in recovery from drug/alcohol use have chronic physical disease. A novel study looks at prevalence of health issues by type of substance used.

Answers to these 5 questions on new research may have you re-thinking treatment strategies for your COPD patients.

"I'm having trouble catching my breath." "I can't pay for my inhaler." "I'm just so sad." They may not tell us, so we need to ask. Here's my experience.

Topics include: Role of antibiotics for acute exacerbations; updates on long-term oxygen therapy; COPD-PCI connection, plus more.

Take this short 5-question quiz to find out what you know--or, what you may have missed--about the latest developments in COPD.

These brief summaries highlight key developments in COPD and how they are likely to affect patient management in the months and years ahead.